启迪药业(000590.SZ)拟收购名实药业55%股权延伸产品线至大健康保健食品及功能性食品

智通财经网01-11

智通财经APP讯，启迪药业(000590.SZ)发布公告，公司与武汉名实药业股份有限公司(简称“名实药业”)的两名股东谈运良(持有名实药业84.7630%股权)和王中(持有名实药业15.2370%股权)及名实药业拟签署《股份转让协议》。公司拟以现金人民币1.41亿元的对价收购转让方持有的名实药业55%股权。据悉，名实药业全资子公司武汉名实生物医药科技有限公司(简称“名实科技”)持有13个国产...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2402242256?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-01-11 20:54","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2402242256","market":"sh","top_or_hot":-1,"title":"启迪药业(000590.SZ)拟收购名实药业55%股权 延伸产品线至大健康保健食品及功能性食品","media":"智通财经网","content":"<div>\n<p>智通财经APP讯，启迪药业(000590.SZ)发布公告，公司与武汉名实药业股份有限公司(简称“名实药业”)的两名股东谈运良(持有名实药业84.7630%股权)和王中(持有名实药业15.2370%股权)及名实药业拟签署《股份转让协议》。公司拟以现金人民币1.41亿元的对价收购转让方持有的名实药业55%股权。据悉，名实药业全资子公司武汉名实生物医药科技有限公司(简称“名实科技”)持有13个国产...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/cn/2024-01-11/doc-inacemiv2571142.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>启迪药业(000590.SZ)拟收购名实药业55%股权 延伸产品线至大健康保健食品及功能性食品</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n启迪药业(000590.SZ)拟收购名实药业55%股权 延伸产品线至大健康保健食品及功能性食品\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-11 20:54 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/relnews/cn/2024-01-11/doc-inacemiv2571142.shtml><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，启迪药业(000590.SZ)发布公告，公司与武汉名实药业股份有限公司(简称“名实药业”)的两名股东谈运良(持有名实药业84.7630%股权)和王中(持有名实药业15.2370%股权)及名实药业拟签署《股份转让协议》。公司拟以现金人民币1.41亿元的对价收购转让方持有的名实药业55%股权。据悉，名实药业全资子公司武汉名实生物医药科技有限公司(简称“名实科技”)持有13个国产...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/cn/2024-01-11/doc-inacemiv2571142.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0122","symbol_name":"高校","start_time":0,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-01-11/doc-inacemiv2571142.shtml","article_id":"2402242256","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-01-11/doc-inacemiv2571142.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2402242256","pubTimestamp":1704977640,"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"公司拟以现金人民币1.41亿元的对价收购转让方持有的名实药业55%股权。名实药业二级子公司华凯保健品持有2个国产保健食品批件，名实药业关联企业健恒生物持有2个保健食品批件。公司表示，本次公司受让名实药业55%股权后，通过本次收购上市公司将产品线延伸至大健康保健食品及功能性食品，有利于化解上市公司产品单一的经营风险，丰富上市公司产品线，实现双方销售渠道的互补，增厚上市公司经营护城河。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0122":"高校","000590":"启迪药业","BK0239":"医药制造"},"translate_title":"Qidi Pharmaceutical (000590. SZ) plans to acquire 55% equity of Mingshi Pharmaceutical and extend its product line to big health food and functional food","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000590":1},"content_text":"智通财经APP讯，启迪药业(000590.SZ)发布公告，公司与武汉名实药业股份有限公司(简称“名实药业”)的两名股东谈运良(持有名实药业84.7630%股权)和王中(持有名实药业15.2370%股权)及名实药业拟签署《股份转让协议》。公司拟以现金人民币1.41亿元的对价收购转让方持有的名实药业55%股权。据悉，名实药业全资子公司武汉名实生物医药科技有限公司(简称“名实科技”)持有13个国产保健食品注册证，8个国产保健食品备案凭证，3个国产特殊用途化妆品批件及1个医疗器械注册证。名实药业二级子公司华凯保健品持有2个国产保健食品批件，名实药业关联企业健恒生物持有2个保健食品批件。公司表示，本次公司受让名实药业55%股权后，通过本次收购上市公司将产品线延伸至大健康保健食品及功能性食品，有利于化解上市公司产品单一的经营风险，丰富上市公司产品线，实现双方销售渠道的互补，增厚上市公司经营护城河。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2402242256"}

启迪药业(000590.SZ)拟收购名实药业55%股权 延伸产品线至大健康保健食品及功能性食品

精彩评论

启迪药业(000590.SZ)拟收购名实药业55%股权延伸产品线至大健康保健食品及功能性食品